deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT01909336

Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia

Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia.

Sponsor: Instituto Tecnologico y de Estudios Superiores de Monterey

Conditions Hyponatremia
Updated 5 times since 2017 Last updated: Oct 21, 2016 Started: Jul 31, 2013 Primary completion: Feb 28, 2014 Completion: Apr 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hyponatremia, this trial is completed. The trial is conducted by Instituto Tecnologico y de Estudios Superiores de Monterey and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto Tecnologico y de Estudios Superiores de Monterey
  • Tecnologico de Monterrey
Data source: Instituto Tecnologico y de Estudios Superiores de Monterey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.